Our strategic partners
The Institute of Cancer Research, London, works closely with a number of funding organisations, including Cancer Research UK, Breast Cancer Now and the Wellcome Trust.
We also have a close partnership with The Royal Marsden NHS Foundation Trust, allowing effective translation of scientific results into new treatments for patients.
The ICR is a college of the University of London and collaborates with many academic organisations in the UK and worldwide on research projects, most notably Imperial College London.
The Royal Marsden NHS Foundation Trust
The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our research rapidly into the clinic, with the aim of developing better treatments for cancer patients.
The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our research rapidly into the clinic, with the aim of developing better treatments for cancer patients.
With hospitals in Chelsea and Sutton, and a chemotherapy suite at Kingston Hospital, The Royal Marsden treats 50,000 patients from across the UK and abroad every year. Many of these patients benefit from tailored treatment programmes accomplished through provision of molecular diagnostics – allowing doctors to determine which specific treatments will be of most benefit to a particular patient.
The ICR and The Royal Marsden are internationally renowned for our work together to conduct early- and late-phase clinical trials. Our joint Drug Development Unit, which sees around 300 patients per year, is one of the largest centres for phase I trials in the world and makes an important contribution to the worldwide effort to discover and develop new cancer drugs.
The ICR and The Royal Marsden together are ranked in the top four centres for cancer research and treatment worldwide. In 2006, we were selected as a National Institute for Health and Care Research Biomedical Research Centre specialising in cancer.
Cancer Research UK
Cancer Research UK grants support our work in designing new cancer therapeutics, and our activities in drug development, cancer imaging and clinical trials.
Cancer Research UK is the world’s largest independent cancer research charity, and the single biggest charitable funder of research at The Institute of Cancer Research.
Many members of faculty hold Cancer Research UK grants, and we gain funding for major programmes of research in cancer biology, genetics and molecular pathology. Cancer Research UK grants also support our work in designing new cancer therapeutics, and our activities in drug development, cancer imaging and clinical trials.
The ICR and The Royal Marsden NHS Foundation Trust are together designated a Cancer Research UK Centre. The centre is a strategic initiative through which Cancer Research UK, the ICR and The Royal Marsden work together on translational and clinical research. It funds research in our Drug Development Unit and in radiotherapy and imaging.
Breast Cancer Now
Breast Cancer Now funds the Breast Cancer Now Breast Cancer Research Centre at The Institute of Cancer Research – the world’s first dedicated breast cancer research centre.
Breast Cancer Now is the UK's leading breast cancer charity and is committed to fighting the disease through research and awareness.
Breast Cancer Now funds the Breast Cancer Now Breast Cancer Research Centre at The Institute of Cancer Research – the world’s first dedicated breast cancer research centre. It brings together 140 scientists and clinicians to focus on breast cancer biology, diagnosis and treatment.
Breast Cancer Now also supports several long-term epidemiological studies at the ICR aiming to learn more about the causes of breast cancer. It funds the Breakthrough Generations Study, the world's most comprehensive study into the causes of breast cancer, and the Male Breast Cancer Study – the largest study into the causes of breast cancer in men.
Breast Cancer Now also runs research units at King’s College London and in the Manchester Cancer Research Centre, and research programmes at the University of Dundee and the University of Edinburgh in Scotland.
Related news
Related blogs
